共 50 条
- [1] Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (02): : 102 - 108
- [2] THE CONTRACEPTIVE USE OF DEPOT MEDROXYPROGESTERONE ACETATE [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 1995, 38 (04): : 849 - 858
- [3] EFFECT OF INJECTION VOLUME ON THE BIOAVAILABILITY OF STERILE MEDROXYPROGESTERONE ACETATE SUSPENSION [J]. CLINICAL PHARMACY, 1983, 2 (05): : 435 - 438
- [4] Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (01): : 22 - 29
- [8] Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (04): : 333 - 334
- [9] USE OF MEDROXYPROGESTERONE ACETATE AS A CONTRACEPTIVE IN CONJUNCTION WITH EARLY POSTPARTUM RUBELLA VACCINATION [J]. BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5890): : 443 - 446